THE EFFECT OF HAPTONOMY PRACTICE ON PREGNANT WOMEN WITH A HISTORY OF ABORTION. (Haptonomy)
THE EFFECT OF HAPTOTHERAPY APPLİCATİON ON PRE-NATAL ATTACHMENT AND ANXİETY LEVELS İN PREG-NANT WOMEN WİTH A HİSTORY OF ABORTİON
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Burcu FIRAT
- Phone Number: +905060503078
- Email: burcum_oskaan@hotmail.com
Study Locations
-
-
Ümraniye
-
Istanbul, Ümraniye, Turkey (Türkiye), 34768
- Uskudar University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Primiparous pregnant women with a history of abortion
- Singleton pregnant women with a healthy pregnancy between 28 and 32 weeks
- Women who conceived naturally
- Pregnant women without psychiatric disorders
- Pregnant women without a diagnosed genetic disease
- Pregnant women without a history of two or more abortions
Exclusion Criteria:
- Pregnant women diagnosed with high-risk pregnancies during the study
- Pregnant women who were included in the study but could not be reached
- Pregnant women who did not continue with the treatment during the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Haptonomy
Pregnant women with prior abortion experience who will undergo haptonia treatment constitute the intervention group.
|
The intervention will be conducted at the antenatal clinic of a Training and Research Hospital.
The training is planned to be conducted face-to-face in groups of 6-8 people in a suitable environment.
Pregnant women included in the intervention group will receive a total of 5 haptonomy sessions, 2 sessions per week.
Each haptonomy session is planned to last 45 minutes.
Group rules will be determined before each training session begins.
The training covers topics such as basic communication and bonding between mother and baby, energy work and visualization, baby communication through breathing techniques, baby communication through suggestion, and baby communication through touch techniques.
The application program, determined according to the schedule, will continue until the last session is completed.
|
|
No Intervention: Control
Pregnant women with a history of abortion and ongoing routine monitoring will be included in the control group.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prenatal Attachment Inventory
Time Frame: 3 months
|
Developed by Müller in 1993, the Prenatal Attachment Inventory (PAI) is used to describe the emotions, thoughts, and situations experienced by women during pregnancy and to determine their level of attachment to the baby during the prenatal period.
It consists of 21 items.
Each item is scored on a 4-point Likert scale, ranging from 1 to 4: 1: Never, 2: Sometimes, 3: Frequently, 4: Always.
The minimum score is 21, and the maximum is 84.
A higher score indicates a higher level of attachment.
In a validity and reliability study of the inventory by Dereli Yılmaz and Kızılkaya Beji (2013), the Cronbach Alpha value was found to be 0.84.
|
3 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stirling Antenatal Anxiety Scale
Time Frame: 3 months
|
Developed by Sinesi and colleagues in 2022, the Stirling Antenatal Anxiety Scale is used to assess the level of prenatal anxiety common in pregnant women.
This scale is a 5-point Likert type and consists of 9 items.
Scale responses are scored as follows: "never" = 0, "rarely" = 1, "sometimes" = 2, "frequently" = 3, "always" = 4.
The Cronbach's Alpha coefficient is 0.88 in the original study and 0.87 in the Turkish validity and reliability study.
The scale scores range from a minimum of 0 to a maximum of 36 points.
A higher score indicates a higher level of anxiety experienced by pregnant women during the antenatal period.
|
3 months
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Nur Yilmaz, A., & Aksoy Derya, Y. (2025). The effects of haptonomy and virtual reality, anxiety, prenatal attachment and acceptance of pregnancy in unplanned pregnancy. Journal of Reproductive and Infant Psychology, 1-15.
- Alivand, Z., Nourizadeh, R., Hakimi, S., Esmaeilpour, K., & Mehrabi, E. (2025). The Effect of Haptonomy on Fear of Childbirth and Maternal-fetal Attachment: A Systematic Review and Meta-analysis. Current Psychiatry Research and Reviews, 21(4), 555-566.
- Atabakhsh T, Salehi K, Mohammadi F. Investigating the impact of haptotherapy on maternal-fetal attachment in unplanned pregnancies. J Educ Health Promot. 2024 Aug 29;13:301. doi: 10.4103/jehp.jehp_8_24. eCollection 2024.
- Ozbek H, Pinar SE. The effect of haptonomy applied to pregnant women on perceived stress, fear of childbirth, and prenatal attachment: randomized controlled experimental study. Curr Psychol. 2022 Jul 16:1-10. doi: 10.1007/s12144-022-03388-1. Online ahead of print.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- UU-SBF-BF-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.